Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides

With recent approvals of antisense oligonucleotides as therapeutics, there is an increasing interest in expanding the application of these compounds to many other diseases. Our laboratory focuses on developing therapeutic splice modulating antisense oligonucleotides to treat diseases potentially ame...

Descripción completa

Detalles Bibliográficos
Autores principales: Aung-Htut, May T., Comerford, Iain, Johnsen, Russell, Foyle, Kerrie, Fletcher, Sue, Wilton, Steve D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736852/
https://www.ncbi.nlm.nih.gov/pubmed/31506448
http://dx.doi.org/10.1038/s41598-019-49385-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736852/
https://www.ncbi.nlm.nih.gov/pubmed/31506448
http://dx.doi.org/10.1038/s41598-019-49385-6

Ejemplares similares